Primary hypertension to predict progression-free survival of target therapy in patients with metastatic renal cell carcinoma.
Zhi Hong Chi
No relevant relationships to disclose
Li Li Mao
No relevant relationships to disclose
Lu Si
No relevant relationships to disclose
Chuan Liang Cui
No relevant relationships to disclose
Xi Nan Sheng
No relevant relationships to disclose
Si Ming Li
No relevant relationships to disclose
Bi Xia Tang
No relevant relationships to disclose
Jun Guo
No relevant relationships to disclose